Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study

International Journal of Epidemiology

Volumn 45, Issue 3, 2016, Pages 929-939

  Guertin, Kristin A ^a   Freedman, Neal D ^a   Loftfield, Erikka ^a   Graubard, Barry I ^b   Caporaso, Neil E ^c   Sinha, Rashmi ^a  

^a Nutritional Epidemiology Branch   (United States)

^b Biostatistics Branch   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Caffeine; Coffee; Lung cancer; Smoking; Tobacco

Indexed keywords

ADULT; ANAPLASTIC CARCINOMA; COFFEE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING; FEMALE; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; REVIEW; SMALL CELL LUNG CANCER; SMOKING; SQUAMOUS CELL LUNG CARCINOMA; TOBACCO USE; AGED; CARCINOMA; DIETARY SUPPLEMENT; DRINKING BEHAVIOR; INCIDENCE; LUNG TUMOR; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

NICOTIANA TABACUM;

AGED; ALCOHOL DRINKING; CARCINOMA; COFFEE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TOBACCO SMOKING; UNITED STATES;

EID: 85039995164     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyv104     Document Type: Review

References (51)

1. American Cancer Society. Cancer Facts and Figures 2015. Atlanta, GA: American Cancer Society, 2015.
2. Farah A. Coffee constituents. In: Chu Y-F (ed). Coffee: Emerging Health Effects and Disease Prevention. Hoboken. NJ: Wiley-Blackwell;2012.
3. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012;366:1891–904.
4. Lai GY, Weinstein SJ, Albanes D et al. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer 2013;109:1344–51.
5. Sinha R, Cross AJ, Daniel CR et al. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 2012;96:374–81.
6. Gunter MJ, Schaub JA, Xue X et al. A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer 2012;131:E530–36.
7. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol 2014;180:763–75.
8. Tang N, Wu Y, Ma J, Wang B, Yu R. Coffee consumption and risk of lung cancer: A meta-analysis. Lung Cancer 2010;67:17–22.
9. Lee PN, Forey BA, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer. BMC Cancer 2012;12:385.
10. Nomura A, Heilbrun LK, Stemmermann GN. Prospective study of coffee consumption and the risk of cancer. J Natl Cancer Inst 1986;76:587–90.
11. Nilsson L, Johansson I, Lenner P, Lindahl B, Van Guelpen B. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 2010; 21:1533–44.
12. Ren JS, Freedman ND, Kamangar F et al. Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study. Eur J Cancer 2010; 46:1873–81.
13. Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994;5:401–08.
14. Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, Moysich KB. Associations between black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutr Cancer 2005;52:15–21.
15. Javed, Luqman M, Daud S, Raheem N, Ahmad J, Khan AUH. Risk factors for lung cancer in the Pakistani population. Asian Pac J Cancer Prev 2014;15:3035–39.
16. Ganesh B, Sushama S, Monika S, Suvarna P. A case-control study of risk factors for lung cancer in Mumbai, India. Asian Pac J Cancer Prev 2011;12:357–62.
17. Jacobsen BK, Bjelke E, Kvale G, Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 1986;76:823–31.
18. Fu YY, Takezaki T, Tajima K. [Risk factors of lung cancer – follow-up studies in Nagoya Japan]. Zhonghua Liu Xing Bing Xue Za Zhi 1997;18:328–30.
19. Takezaki T, Hirose K, Inoue M et al. Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas. Br J Cancer 2001;84:1199–206.
20. Chow WH, Schuman LM, McLaughlin JK et al. A cohort study of tobacco use, diet, occupation, and lung cancer mortality. Cancer Causes Control 1992;3:247–54.
21. Hu J, Mao Y, Dryer D, White K. Risk factors for lung cancer among Canadian women who have never smoked. Cancer Detect Prev 2002;26:129–38.
22. Mettlin C. Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer 1989;43:608–12.
23. Mendilaharsu M, De Stefani E, Deneo-Pellegrini H, Carzoglio JC, Ronco A. Consumption of tea and coffee and the risk of lung cancer in cigarette-smoking men: a case-control study in Uruguay. Lung Cancer 1998;19:101–07.
24. Nyberg F, Agrenius V, Svartengren K, Svensson C, Pershagen G. Dietary factors and risk of lung cancer in never-smokers. Int J Cancer 1998;78:430–36.
25. Axelsson G, Liljeqvist T, Andersson L, Bergman B, Rylander R. Dietary factors and lung cancer among men in west Sweden. Int J Epidemiol 1996;25:32–39.
26. Khan MM, Goto R, Kobayashi K et al. Dietary habits and cancer mortality among middle aged and older Japanese living in Hokkaido, Japan by cancer site and sex. Asian Pac J Cancer Prev 2004;5:58–65.
27. Kubik A, Zatloukal P, Tomasek L et al. A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma 2008;55:192–99.
28. Sanikini H, Radoï L, Menvielle G et al. Coffee consumption and risk of lung cancer: the ICARE study. Eur J Epidemiol 2015;30: 81–85.
29. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 2001;31:139–48.
30. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25:561–70.
31. Loftfield E, Freedman ND, Graubard BI et al. Coffee drinking and cutaneous melanoma risk in the NIH-AARP Diet and Health Study. J Natl Cancer Inst 2015;107(2). doi: 10.1093/jnci/ dju421.
32. Gierach GL, Freedman ND, Andaya A et al. Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. Int J Cancer 2012;131:452–60.
33. Schatzkin A, Subar AF, Thompson FE et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001; 154:1119–25.
34. Michaud DS, Midthune D, Hermansen S et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manag 2005;32:70–7.
35. World Health Organization. International Classification of Diseases for Oncology. ICD-O-3. 3rd edn. Geneva: WHO, 2010.
36. Brinton LA, Gierach GL, Andaya A et al. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev 2011; 20:900–11.
37. Freedman LS, Schatzkin A, Wax Y. The impact of dietary measurement error on planning sample size required in a cohort study. Am J Epidemiol 1990;132:1185–95.
38. Wang Y, Yu X, Wu Y, Zhang D. Coffee and tea consumption and risk of lung cancer: a dose-response analysis of observational studies. Lung Cancer 2012;78:169–70.
39. Rodenburg EM, Eijgelsheim M, Geleijnse JM et al. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking. Am J Clin Nutr 2012;96:182–87.
40. Cornelis MC, Monda KL, Yu K et al. Genome-wide meta-analysis identifies regions on 7p21 and 15q24 as determinants of habitual caffeine consumption. PLoS Genet 2011;7:e1002033.
41. Sulem P, Gudbjartsson DF, Geller F et al. Sequence variants at CYP1A1–CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet 2011;20:2071–77.
42. Amin N, Byrne E, Johnson J et al. Genome-wide association analysis of coffee drinking suggests association with CYP1A1/ CYP1A2 and NRCAM. Mol Psychiatry 2012;17:1116–29.
43. Gunes A, Dahl ML. Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics 2008;9:625–37.
44. Campbell ME, Spielberg SP, Kalow W. A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 1987;42:157–65.
45. Kalow W, Tang BK. Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 1991;50(5 Pt 1):508–19.
46. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915–20.
47. Applebaum KM, Malloy EJ, Eisen EA. Left Truncation, Susceptibility, and Bias in Occupational Cohort Studies. Epidemiology 2011;22:599–606.
48. Hernan MA, Alonso A, Logan R et al. Observational studies analyzed like randomized experiments an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 2008;19:766–79.
49. Flanders WD, Eldridge RC, McClellan W. A nearly unavoidable mechanism for collider bias with index-event studies. Epidemiology 2014;25:762–64.
50. Schatzkin A, Kipnis V. Could exposure assessment problems give us wrong answers to nutrition and cancer questions? J Natl Cancer Inst 2004;96:1564–65.
51. Michaud DS, Midthune D, Hermansen S et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manag 2005;32:70–5.